Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 29, Issue 2, pp. 368-378
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 15, 2019
- Revision received August 8, 2019
- Accepted November 22, 2019
- Published first December 2, 2019.
Article Versions
- Previous version (December 2, 2019 - 04:01).
- Previous version (January 22, 2020 - 06:00).
- Previous version (January 27, 2020 - 06:05).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Hongyan Li1,
- Mary Beth Terry2,3,
- Antonis C. Antoniou4,
- Kelly-Anne Phillips5,6,7,
- Karin Kast8,9,10,
- Thea M. Mooij11,
- Christoph Engel12,
- Catherine Noguès13,
- Dominique Stoppa-Lyonnet14,15,
- Christine Lasset16,
- Pascaline Berthet17,
- Veronique Mari18,
- Olivier Caron19,
- for the GENEPSO study,
- Daniel Barrowdale4,
- Debra Frost4,
- Carole Brewer20,
- D. Gareth Evans21,
- Louise Izatt22,
- Lucy Side23,
- Lisa Walker24,
- Marc Tischkowitz25,
- Mark T. Rogers26,
- Mary E. Porteous27,
- Katie Snape28,
- for the EMBRACE study,
- Hanne E.J. Meijers-Heijboer29,
- Johan J.P. Gille29,
- Marinus J. Blok30,
- Nicoline Hoogerbrugge31,
- for the HEBON Investigators,
- Mary B. Daly32,
- Irene L. Andrulis33,34,
- Saundra S. Buys35,
- Esther M. John36,
- Sue-Anne McLachlan37,38,
- Michael Friedlander39,40,
- for the kConFab Investigators,
- Yen Y. Tan41,
- Ana Osorio42,
- Trinidad Caldes43,
- Anna Jakubowska44,45,
- Jacques Simard46,
- Christian F. Singer41,
- Edith Olah47,
- Marie Navratilova48,
- Lenka Foretova48,
- Anne-Marie Gerdes49,
- Marie-José Roos-Blom11,
- Brita Arver50,51,
- Håkan Olsson51,
- Rita K. Schmutzler52,53,
- John L. Hopper5,
- Roger L. Milne5,54,55,
- Douglas F. Easton4,56,
- Flora E. Van Leeuwen11,
- Matti A. Rookus11,
- Nadine Andrieu57,58,59,60,#,*, and
- David E. Goldgar1,61,#,*
- 1Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah.
- 2Department of Epidemiology, Columbia University, New York, New York.
- 3Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
- 4Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, United Kingdom.
- 5Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria, Australia.
- 6The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
- 7Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- 8Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität, Dresden, Germany.
- 9National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany.
- 10German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 11Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
- 12Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany.
- 13Institut Paoli-Calmettes, Département d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique and Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France.
- 14Institut Curie, Service de Génétique Médicale, Paris, France.
- 15Inserm, U830, Université Paris Descartes, Paris, France.
- 16Unité de prévention et Epidémiologie Génétique, Centre Léon Bérard - Lyon/UMR CNRS 5558, Université de Lyon – Lyon, France.
- 17Département de biopathologie, Oncogénétique clinique, Centre François Baclesse – Caen, France.
- 18CLCC Antoine Lacassagne, Département d'Hématologie - Oncologie médicale, Nice, France.
- 19Département de Médecine, Gustave Roussy Hôpital Universitaire – Villejuif, France.
- 20Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom.
- 21Genomic Medicine, NIHR Manchester Biomedical Research Centre, Manchester Academic Health Sciences Centre, Division of Evolution and Genomic Sciences, Manchester University, Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
- 22Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
- 23Wessex Clinical Genetics Service, The Princess Anne Hospital, Southampton, United Kingdom.
- 24Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom.
- 25University of Cambridge Department of Medical Genetics, NIHR Cambridge Biomedical Research Centre, and Cancer Research UK Cambridge Center, Cambridge Biomedical Campus, Cambridge, United Kingdom.
- 26All Wales Medical Genetics Services, University Hospital of Wales, Cardiff, United Kingdom.
- 27South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom.
- 28Medical Genetics Unit, St. George's, University of London, London, United Kingdom.
- 29Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
- 30Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands.
- 31Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
- 32Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
- 33Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
- 34Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
- 35Department of Medicine, University of Utah Health Sciences Center, Huntsman Cancer Institute, Salt Lake City, Utah.
- 36Stanford University School of Medicine, Department of Medicine, Division of Oncology, and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
- 37Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Parkville, Victoria, Australia.
- 38Department of Medical Oncology, St. Vincent's Hospital, Fitzroy, Victoria, Australia.
- 39Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
- 40Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- 41Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
- 42Human Genetics Group, Spanish National Cancer Centre (CNIO) and Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
- 43Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, CIBERONC (ISCIII), Madrid, Spain.
- 44Department of Genetics and Pathology, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, Poland.
- 45Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
- 46Genomics Center, Centre Hospitalier Universitaire de Québec – Université Laval Research Center, Quebec City, Quebec, Canada.
- 47Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
- 48Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, Czech Republic.
- 49The Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
- 50Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- 51Department of Oncology, Lund University Hospital, Lund, Sweden.
- 52Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
- 53Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
- 54Division of Cancer Epidemiology and Intelligence, Cancer Council Victoria, Melbourne, Australia.
- 55Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
- 56Centre for Cancer Genetic Epidemiology, Department of Oncology, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, United Kingdom.
- 57INSERM, U900, Paris, France.
- 58Institut Curie, Paris, France.
- 59Mines Paris Tech, Fontainebleau, France.
- 60PSL Research University, Paris, France.
- 61Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah.
- ↵*Corresponding Authors:
David E. Goldgar, University of Utah School of Medicine, 30 N. Medical Drive, Salt Lake City, UT 84132. Phone: 801-581-6465; Fax: 801-581-6484; E-mail: david.goldgar{at}hsc.utah.edu; and Nadine Andrieu, Cancer Genetic Epidemiology Team, INSERM Unit 900, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Phone: 3301-7238-9383; E-mail: nadine.andrieu{at}curie.fr
↵#N. Andrieu and D.E. Goldgar are co-senior authors for this article.
February 2020
Volume 29, Issue 2
Volume 29, Issue 2
Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium
Jump to section
Advertisement